Valiant Organics Ltd

Valiant Organics Limited will hold a board meeting on Thursday, November 05, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The trading window for the company's securities will remain closed until November 07, 2026.

Valiant Organics Limited informed the BSE and National Stock Exchange that it received a certificate from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter and half year ended September 30, 2026, noting that all securities of the company are held in dematerialized form.

Valiant Organics Limited announced that shareholders approved the re-appointment of Shri Nemin M. Savadia and Shri Santosh S. Vora at the company’s 21st Annual General Meeting on September 29, 2026, and the re-appointment of Shri Sathiababu K. Kallada as Managing Director for a term of 3 years, effective May 24, 2027.

Valiant Organics Limited informed the BSE and National Stock Exchange of India that the trading window for securities of the company will be closed for directors, promoters, promoter group, designated persons, and their immediate relatives and connected persons, effective October 1, 2026, until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026, in accordance with SEBI regulations.

Valiant Organics Ltd share price inched up 4.66% to Rs 311.0 after the company's net profit surged by 86.13% to Rs 29.26 crore, while revenue from operations slightly gained 6.32% to Rs 231.54 crore in Q2FY26 over Q1FY26. The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.14 lakh crore, heading higher 14.89%. It has marginally improved by 1.63% over last one week and heading higher by 11.57% in last one month while the market capitalization of Valiant Organics Ltd has improved by 6.80% and 9.58% in the same period respectively. Profit before tax (PBT) of Valiant Organics Ltd stood at Rs 36.78 crore in Q2 FY26, jumping 231.05% year-on-year, and rallying 109.57% quarter-on-quarter. EBITDA came in at Rs 38 crore, surging by 61.16% YoY and expanding by 70.63% sequentially. Total expenses marginally dropped 0.69% to Rs 200.14 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 150.32 crore, witnessing a sharp rise of 23.40% YoY, while employee benefits expense was at Rs 13.11 crore, dipping slightly 1.65% YoY. For the TTM ended FY26, revenue from operations eased 0.59% to Rs 718.76 crore, while net profit witnessed a sharp fall of 59.17% to Rs 3.43 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 2879% to Rs 45.17 crore, and PBT tanked by 124.74% to Rs 2.15 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 56.43 crore in FY26, as against Rs 84.0 crore in FY25. Valiant Organics Ltd tumbled by 8.61% in last one year, underperforming the benchmark BSE Sensex which has softened by 3.04% during the same period.

Valiant Organics Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The trading window for the company's securities will remain closed until August 14, 2026.

Valiant Organics Ltd announced a credit rating intimation from CRISIL Ratings Limited concerning its various debt instruments. CRISIL Ratings Limited has assigned a rating of "CRISIL A-/Stable" to the company's Rs 750 crore of long term bank loan facilities and a rating of "CRISIL A2" to its Rs 250 crore of short term bank loan facilities, with no enhancements or assignments noted; the ratings were previously held and remain unchanged, with no withdrawals reported.

Valiant Organics Ltd announced today that CRISIL Ratings Limited has issued an intimation under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, referencing a credit rating; however, specific details regarding the instrument, amount, rating, or action taken by CRISIL Ratings Limited were not provided, and no other rating agencies have issued enhancements, assignments, or withdrawals related to any instruments for Valiant Organics Ltd.

Net profit of Valiant Organics rose 274.29% to Rs 15.72 crore in the quarter ended March 2026 as against Rs 4.20 crore during the previous quarter ended March 2025. Sales rose 6.85% to Rs 217.78 crore in the quarter ended March 2026 as against Rs 203.81 crore during the previous quarter ended March 2025. For the full year,net profit reported to Rs 33.24 crore in the year ended March 2026 as against net loss of Rs 3.74 crore during the previous year ended March 2025. Sales rose 2.78% to Rs 738.76 crore in the year ended March 2026 as against Rs 718.76 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales217.78203.81 7 738.76718.76 3 OPM %12.1610.15 -11.787.40 - PBDT27.8016.54 68 75.7837.91 100 PBT17.557.34 139 36.212.15 1584 NP15.724.20 274 33.24-3.74 LP Powered by Capital Market - Live

Valiant Organics will hold a meeting of the Board of Directors of the Company on 16 May 2026.